Geneva, October 31, 2012

Panel I: “Innovation Today: Treading New Ground to Meet Global Health Needs”

Cary Adams, CEO, Union for International Cancer Control
Nigel Darby, Vice President of Biotechnologies, Chief Technology Officer GE Healthcare
David Khayat, Professor and Head of Medical Oncology, Pitié-Salpêtrière Hospital
John Lechleiter, Chairman, President, and CEO, Eli Lilly & Company
Mary Lou Valdez, Associate Commissioner for International Programs, U.S. Food and Drug Administration

About IFPMA

IFPMA represents the innovative pharmaceutical industry at the international level, engaging in official relations with the United Nations and multilateral organizations. Our vision is to ensure that scientific progress translates into the next generation of medicines and vaccines that deliver a healthier future for people everywhere.

To achieve this, we act as a trusted partner, bringing our members' expertise to champion pharmaceutical innovation, drive policy that supports the research, development, and delivery of health technologies, and create sustainable solutions that advance global health.

ifpma.org

Media Contact

Elliot Dunster e.dunster@ifpma.org